• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补骨脂素加紫外线A疗法(PUVA)与甲氨蝶呤联合使用对斑块型银屑病疾病清除时间的疗效。

Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis.

作者信息

Shehzad T, Dar N R, Zakria M

机构信息

Department of Dermatology, Naval Hospital PNS Shifa, Karachi.

出版信息

J Pak Med Assoc. 2004 Sep;54(9):453-5.

PMID:15518366
Abstract

OBJECTIVE

To document the efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis.

METHOD

Sixty male patients between 18 to 50 years of age suffering from plaque type of psoriasis with PASI score more than 10 were enrolled in the study between March 2001 to November 2001. They were divided into three groups of 20 patients each. Group A received only PUVA, Group B received only Methotrexate and group C received both PUVA and Methotrexate concomitantly. PUVA was given four times a week according to11011 schedule. The end point for clearance of psoriasis was taken as 75% reduction in PASI score from the baseline.

RESULTS

Group A: The minimum number of PUVA sessions needed for clearance was 20 and the maximum number was 25 (mean - 22.5). The mean clearance time was 5.5 weeks. The cumulative dose of UVA radiation ranged from 150-250 J/cm2 (mean -200 J/cm2). Group B: The time required for clearance was 7 weeks at the minimum and 9 weeks at the maximum (mean - 8 weeks). Group C: The minimum number of PUVA sessions needed for clearance was 8 and maximum was 12 (mean 10). The mean time for clearance was 2.5 weeks. The cumulative dose of UVA radiation ranged from 56-108 J/cm2 (mean-82 J/cm2). No significant side effects were seen in the three treatment groups.

CONCLUSION

The results suggest that combination of PUVA and methotrexate is an effective and safe modality for clearance of psoriasis.

摘要

目的

记录补骨脂素紫外线A光化学疗法(PUVA)与甲氨蝶呤联合使用对斑块型银屑病疾病清除时间的疗效。

方法

2001年3月至2001年11月,纳入60例年龄在18至50岁之间、斑块型银屑病患者,其银屑病面积和严重程度指数(PASI)评分超过10分。他们被分为三组,每组20例患者。A组仅接受PUVA治疗,B组仅接受甲氨蝶呤治疗,C组同时接受PUVA和甲氨蝶呤治疗。PUVA按照11011方案每周进行4次。银屑病清除的终点定义为PASI评分较基线降低75%。

结果

A组:清除所需的PUVA治疗最少次数为20次,最多为25次(平均 - 22.5次)。平均清除时间为5.5周。紫外线A辐射的累积剂量范围为150 - 250 J/cm²(平均 - 200 J/cm²)。B组:清除所需时间最短为7周,最长为9周(平均 - 8周)。C组:清除所需的PUVA治疗最少次数为8次,最多为12次(平均10次)。平均清除时间为2.5周。紫外线A辐射的累积剂量范围为56 - 108 J/cm²(平均 - 82 J/cm²)。三个治疗组均未观察到明显的副作用。

结论

结果表明,PUVA与甲氨蝶呤联合使用是清除银屑病的一种有效且安全的方式。

相似文献

1
Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis.补骨脂素加紫外线A疗法(PUVA)与甲氨蝶呤联合使用对斑块型银屑病疾病清除时间的疗效。
J Pak Med Assoc. 2004 Sep;54(9):453-5.
2
Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.减少治疗频率和UVA剂量并不会显著损害口服补骨脂素-UVA的抗银屑病效果。
J Am Acad Dermatol. 2004 Nov;51(5):746-54. doi: 10.1016/j.jaad.2004.04.029.
3
Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis.窄谱中波紫外线光疗联合甲氨蝶呤与单纯窄谱中波紫外线及单纯甲氨蝶呤治疗斑块状银屑病的疗效比较研究
Int J Dermatol. 2014 Dec;53(12):1531-5. doi: 10.1111/ijd.12444. Epub 2014 Apr 16.
4
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.采用银屑病面积和严重程度指数评分(改善75%或更高),对口服补骨脂素加紫外线A治疗斑块型银屑病的疗效进行随机、双盲、安慰剂对照评估,为期12周。
J Am Acad Dermatol. 2009 Nov;61(5):793-8. doi: 10.1016/j.jaad.2009.04.053. Epub 2009 Sep 18.
5
A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study).补骨脂素与紫外线A对深色皮肤类型银屑病患者不同治疗频率的比较研究(随机对照研究)
Photodermatol Photoimmunol Photomed. 2008 Feb;24(1):38-42. doi: 10.1111/j.1600-0781.2008.00334.x.
6
A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.卡泊三醇乳膏与补骨脂素紫外线A光化学疗法(PUVA)联合治疗可降低紫外线A(UVA)剂量,并改善寻常型银屑病的疗效。
J Dermatolog Treat. 2004 Apr;15(2):98-103. doi: 10.1080/09546630410023322.
7
[Treatment of plaque-type psoriasis with cream-PUVA therapy].[乳膏-补骨脂素紫外线A光化学疗法治疗斑块型银屑病]
Hautarzt. 2001 Oct;52(10):885-7. doi: 10.1007/s001050170053.
8
Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.1毫克/升与5毫克/升甲氧沙林浴光化学疗法治疗慢性斑块型银屑病的随机双盲比较
J Am Acad Dermatol. 2006 Oct;55(4):627-31. doi: 10.1016/j.jaad.2006.05.024.
9
Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.慢性斑块状银屑病治疗的随机双盲试验:补骨脂素-紫外线A疗法与窄谱紫外线B疗法的疗效比较
Arch Dermatol. 2006 Jul;142(7):836-42. doi: 10.1001/archderm.142.7.836.
10
Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.甲氨蝶呤与羟基脲每周一次治疗中重度慢性斑块状银屑病的比较研究
J Dermatolog Treat. 2007;18(5):295-300. doi: 10.1080/09546630701499291.

引用本文的文献

1
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2025 Aug 6;8(8):CD011535. doi: 10.1002/14651858.CD011535.pub7.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药物治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2023 Jul 12;7(7):CD011535. doi: 10.1002/14651858.CD011535.pub6.
3
Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources.
资源有限国家蕈样肉芽肿治疗的建议指南。
Dermatol Res Pract. 2023 Jan 31;2023:1360740. doi: 10.1155/2023/1360740. eCollection 2023.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Efficacy of Methotrexate in patients with plaque type psoriasis.甲氨蝶呤治疗斑块状银屑病患者的疗效。
Pak J Med Sci. 2014 Sep;30(5):1050-3. doi: 10.12669/pjms.305.4451.